Join
This site is intended for healthcare professionals
1
Managing Adverse Events in HR+/HER2– Advanced Breast Cancer
2
An FDA Approval for Certain Patients with Endometrial Cancer
3
Birth Rate in England and Wales Falls to Record Low
4
Arsenic Exposure Linked to Higher Urologic Cancer Risk
5
Stem-Cell Therapy Success in China Marks Milestone in Type 1 Diabetes Treatment
Rethinking Immune Tolerance and Chronic Diseases: Interview with Cezmi Akdis
Climate Change Could Triple Cardiovascular Disease Burden by 2050
Phototherapy Remains Effective and Safe in Elderly Psoriasis Patients
Study Reveals Distinct Epigenetic Signatures in Diabetes
FDA unveils new plan for genome therapy editing
Type 2 Diabetes Remission: Interview with Roy Taylor
Microbiome Maturation Influences Neurodevelopmental Disorder Risk
Longer Cosmetic Consultations Boost Treatment Uptake
CAR-T Trial Access Lower for People With HIV
Immune Side Effects Linked to Better Survival in Biliary Tract Cancer
Robotic and Endoscopic Mastectomy Shows Comparable Outcomes
EuroPCR 2026 Interview: Nicolas Dumonteil
EMJ Microbiology & Infectious Diseases 7.1 2026
Plant-Based Diet Linked to Lower Mortality in CKD: ERA 2026
AMJ Neurology 3.1 2026
Stereotactic Radiotherapy Effective in Kidney Cancer
Saline Tract Sealing Reduces Pneumothorax Risk After Lung Biopsy
Antidiabetic Drugs Target Urinary E. coli – EMJ
Sleep Changes May Flag Respiratory Decline in ALS
EMJ Rheumatology 13 [Supplement 1] 2026
ADCs Show Strong Activity in Advanced Urothelial Carcinoma